To date, four vaccines have been authorised for emergency use and under conditional
approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 …

Introduction Pregnant and breastfeeding women are at an increased risk of severe illness
from COVID-19. Despite this, low vaccination coverages are reported in this population sub …

Background Pregnant women are at high risk for affliction by coronavirus disease 2019
(COVID-19). Vaccination is a main strategy to prevent and manage the COVID-19 pandemic …

The progress in the development of various vaccine platforms against SARS-CoV-2 have
been rather remarkable owing to advancement in molecular and biologic sciences. Most of …

Effective strategies are urgently needed to decrease the risk of untoward outcomes of
pregnant women with severe acute respiratory syndrome coronavirus 2 (coronavirus …

The ongoing COVID-19 pandemic is raising great concern all over the world. The recent
introduction of vaccines has offered reason for optimism, however, new issues have arisen …

Background People with pre-existing chronic diseases are more likely to acquire COVID-19
infections, which can be fatal, and die from COVID-19 illness. COVID-19 vaccination will …

Objective To assess the clinical effectiveness of the BNT162b2 vaccine during pregnancy in
preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hospitalizations …

The impact of the COVID-19 infection, caused by Severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), during the pandemic has been considerably more severe in …

In light of the COVID-19 pandemic, researchers across the world hastened to develop
vaccines that would aid in bolstering herd immunity. Utilizing mRNA coding and viral vector …